This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective
Review
Does route of administration affect the outcome of TNF antagonist therapy?
Arthritis Res Ther 2004, 6(Suppl 2):S19-S23 doi:10.1186/ar996
No comments have yet been made on this article.
